Related Links
Current Releases
Stock Quote
Standard & Poor's
SEC Filings
Mailing List
Releases Archives
Opexa Therapeutics Headlines
10/23/2006 - 10:45 AM
Opexa Therapeutics to Present at C.E. Unterberg, Towbin Life Sciences Investor Conference
09/18/2006 - 08:00 AM
Opexa Commences Phase IIb Multiple Sclerosis Study; Reports Positive Phase I/II Data; Provides Update on Preclinical Progress
09/01/2006 - 07:22 AM
Opexa Shares to Trade on NASDAQ Global Market
08/14/2006 - 12:30 PM
Opexa Reports Second Quarter Financial Results
06/26/2006 - 01:46 PM
Scientists at Opexa Therapeutics Generate Human Insulin-Producing Islet Clusters in Culture from Monocyte-Derived Stem Cells
06/19/2006 - 06:00 AM
PharmaFrontiers Changes Name to Opexa Therapeutics; New Ticker Symbol is OPXA
06/16/2006 - 12:44 PM
PharmaFrontiers Appoints Michael Richman to Board of Directors
06/06/2006 - 10:24 AM
PharmaFrontiers to Present at Marcus Evans Conference, ``Facing Stem Cell Research Challenges''
05/15/2006 - 03:48 PM
PharmaFrontiers Reports First Quarter 2006 Results
05/03/2006 - 07:00 AM
PharmaFrontiers Names Lynne Hohlfeld Vice President of Finance
04/17/2006 - 08:00 AM
PharmaFrontiers Completes $23 Million Financing to Advance Therapeutics; Plans Reverse Stock Split
04/17/2006 - 08:00 AM
PharmaFrontiers Appoints Gregory Bailey, M.D. and Scott Seaman, CPA, to Board of Directors
04/13/2006 - 10:45 AM
PharmaFrontiers to Present Data on Adult Human T-Cell Vaccination Technology at the Federation of Clinical Immunology Societies Annual Meeting
04/06/2006 - 07:00 AM
PharmaFrontiers to Present at BIO 2006 Business Forum
03/31/2006 - 04:00 PM
PharmaFrontiers Reports Year End 2005 Financial Results
03/28/2006 - 08:00 AM
PharmaFrontiers to Present Data on Adult Human T-Cell and Stem Cell Technologies at the International Society for Cellular Therapy Annual Meeting
03/22/2006 - 07:00 AM
PharmaFrontiers to Present Tovaxin(TM) Research at Consortium of Multiple Sclerosis Centers' Annual Meeting
02/23/2006 - 11:37 AM
PharmaFrontiers Announces Financing Plans
01/17/2006 - 08:00 AM
PharmaFrontiers Acquires Autologous T Cell Vaccine Rights for Rheumatoid Arthritis
12/01/2005 - 12:09 PM
PharmaFrontiers Appoints Mathilda Mandel to Clinical Advisory Board
11/15/2005 - 07:30 AM
PharmaFrontiers Shareholders Approve Increase in Authorized Shares at Special Meeting
11/15/2005 - 07:00 AM
PharmaFrontiers Reports Third Quarter 2005 Financial Results; Provides Update on Research & Development Activities
11/09/2005 - 08:30 AM
PharmaFrontiers Corp. Selects MDB Capital Group as Financial Advisor
11/08/2005 - 08:51 AM
PharmaFrontiers Corp Elects Brooks Boveroux as Chairman; To Assume Primary Responsibility for Finance
11/02/2005 - 06:00 AM
PharmaFrontiers Corp. to Present at Rodman & Renshaw Techvest Seventh Annual Healthcare Conference
1
2
3
4
5
« Previous
Next »
Releases Archives
